Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-032609
Filing Date
2022-05-27
Accepted
2022-05-27 17:00:55
Documents
1
Period of Report
2022-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6663
  Complete submission text file 0001209191-22-032609.txt   8068
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2292 FARADAY AVENUE CARLSBAD CA 92008
Business Address
KISNER DANIEL L (Reporting) CIK: 0001073407 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 22978683